Metastatic

Elana Gotkine THURSDAY, June 8, 2023 (HealthDay News) -- For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in…

TUESDAY, June 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration approved Lynparza (olaparib) with abiraterone and prednisone (or prednisolone) for adult patients with deleterious or suspected deleterious BRCA-mutated,…

Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor…

Acting as a team, twin stem cells activate the immune system to suppress tumor growth and prolong survival in representative preclinical models. Overall survival for patients with melanoma that has spread to the brain is only four to six…

CHICAGO, June 05, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers harboring ESR1 mutations, today…

26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering               Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company…

<!-- Name:DistributionId Value:8847048 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

Oncolytics Biotech (ONCY) Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Oncolytics Biotech (NASDAQ:)® Inc. (ONCY) today announced positive results from BRACELET-1, a randomized phase 2…

<!-- Name:DistributionId Value:1000821761 --> <!-- Name:NewsArchiveOrgTags Value:Financial#Financial Releases;General#General Releases -->…

<!-- Name:DistributionId Value:8844045 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…